Related Research Articles
Scabies is a contagious skin infestation by the mite Sarcoptes scabiei. The most common symptoms are severe itchiness and a pimple-like rash. Occasionally, tiny burrows may appear on the skin. In a first-ever infection, the infected person usually develops symptoms within two to six weeks. During a second infection, symptoms may begin within 24 hours. These symptoms can be present across most of the body or just certain areas such as the wrists, between fingers, or along the waistline. The head may be affected, but this is typically only in young children. The itch is often worse at night. Scratching may cause skin breakdown and an additional bacterial infection in the skin.
Mange is a type of skin disease caused by parasitic mites. Because various species of mites also infect plants, birds and reptiles, the term "mange", or colloquially "the mange", suggesting poor condition of the skin and fur due to the infection, is sometimes reserved for pathological mite-infestation of nonhuman mammals. Thus, mange includes mite-associated skin disease in domestic mammals, in livestock, and in wild mammals. Since mites belong to the arachnid subclass Acari, another term for mite infestation is acariasis.
Ivermectin is an antiparasitic drug. After its discovery in 1975, its first uses were in veterinary medicine to prevent and treat heartworm and acariasis. Approved for human use in 1987, today it is used to treat infestations including head lice, scabies, river blindness (onchocerciasis), strongyloidiasis, trichuriasis, ascariasis and lymphatic filariasis. It works through many mechanisms to kill the targeted parasites, and can be taken orally, or applied to the skin for external infestations. It belongs to the avermectin family of medications.
Albendazole is a broad-spectrum anthelmintic and antiprotozoal agent of the benzimidazole type. It is used for the treatment of a variety of intestinal parasite infections, including ascariasis, pinworm infection, hookworm infection, trichuriasis, strongyloidiasis, taeniasis, clonorchiasis, opisthorchiasis, cutaneous larva migrans, giardiasis, and gnathostomiasis, among other diseases.
Meloxicam, sold under the brand name Mobic among others, is a nonsteroidal anti-inflammatory medication (NSAID) used to treat pain and inflammation in rheumatic diseases and osteoarthritis. It is used by mouth or by injection into a vein. It is recommended that it be used for as short a period as possible and at a low dose.
Dirofilaria immitis, also known as heartworm or dog heartworm, is a parasitic roundworm that is a type of filarial worm, a small thread-like worm, that causes dirofilariasis. It is spread from host to host through the bites of mosquitoes. There are four genera of mosquitoes that transmit dirofilariasis, Aedes, Culex, Anopheles, and Mansonia. The definitive host is the dog, but it can also infect cats, wolves, coyotes, jackals, foxes, ferrets, bears, seals, sea lions and, under rare circumstances, humans.
Selamectin is a topical parasiticide and anthelminthic used on dogs and cats. It treats and prevents infections of heartworms, fleas, ear mites, sarcoptic mange (scabies), and certain types of ticks in dogs, and prevents heartworms, fleas, ear mites, hookworms, and roundworms in cats. It is structurally related to ivermectin and milbemycin. Selamectin is not approved for human use.
Moxidectin is an anthelmintic drug used in animals to prevent or control parasitic worms (helminths), such as heartworm and intestinal worms, in dogs, cats, horses, cattle and sheep. Moxidectin kills some of the most common internal and external parasites by selectively binding to a parasite's glutamate-gated chloride ion channels. These channels are vital to the function of invertebrate nerve and muscle cells; when moxidectin binds to the channels, it disrupts neurotransmission, resulting in paralysis and death of the parasite.
The health of dogs is a well studied area in veterinary medicine.
Toxocara cati, also known as the feline roundworm, is a parasite of cats and other felids. It is one of the most common nematodes of cats, infecting both wild and domestic felids worldwide. Adult worms are localised in the gut of the host. In adult cats, the infection – which is called toxocariasis – is usually asymptomatic. However, massive infection in juvenile cats can be fatal.
Toxascaris leonina is a common parasitic roundworm found in dogs, cats, foxes, and related host species. T. leonina is an ascarid nematode, a worldwide distributed helminth parasite which is in a division of eukaryotic parasites that, unlike external parasites such as lice and fleas, live inside their host. The definitive hosts of T. leonina include canids and felines (cats), while the intermediate hosts are usually rodents, such as mice or rats. Infection occurs in the definitive host when the animal eats an infected rodent. While T. leonina can occur in either dogs or cats, it is far more frequent in cats.
The combination milbemycin oxime/lufenuron is a parasite control drug in which the active ingredient, milbemycin oxime, eliminates worms, while a second active ingredient, lufenuron, arrests the development of eggs and larvae, preventing them from maturing and continuing the infestation of an animal. This combination is registered for animal use only. To achieve efficacy, the treatment is administered once monthly, together with food, in a dosage suitable for the weight of the affected animal. The usual ratio is 500 μg milbemycin oxime and 10 mg lufenuron/kg body weight. Novartis indicates the proper dosage by color-coding the packages.
Pyriprole is for veterinary use on dogs against external parasites such as fleas and ticks.
Imidacloprid/permethrin/pyriproxyfen, sold under the trade name K9 Advantix II, is a combination insecticide product for dogs, used for the treatment and prevention of an array of common external parasites. It is effective against fleas, ticks, chewing lice and mosquitoes. The active ingredients are imidacloprid, permethrin, and pyriproxyfen. This product is toxic to cats, and it is not recommended to use it on dogs which share an environment with cats. The product is applied onto the skin; administration of the product into the mouth can cause adverse effects.
Fluralaner (INN) is a systemic insecticide and acaricide that is administered orally or topically. The U.S. Food and Drug Administration (FDA) approved it under the trade name Bravecto for flea treatment in dogs in May 2014 and Bravecto Plus as a topical treatment for cats in November 2019, with warnings about possible side effects in both species. The EU approved the drug in February 2014. Australia approved it for the treatment and prevention of ticks and fleas on dogs in January 2015.
Trifarotene, sold under the brand name Aklief, is a medication for the topical treatment of acne vulgaris. It is a retinoid; more specifically, it is a fourth generation selective retinoic acid receptor (RAR)-γ agonist.
Lotilaner, sold under the brand name Credelio, is a veterinary medication used to control fleas and ticks in dogs and cats. It is indicated for the treatment and prevention of flea infestations and for the treatment and control of tick infestations including lone star tick, American dog tick, black-legged tick, and brown dog tick.
Notoedric mange, also referred to as Feline scabies, is a highly contagious skin infestation caused by an ectoparasitic and skin burrowing mite Notoedres cati. N. cati is primarily a parasite of felids, but it can also infest rodents, lagomorphs, and occasionally also dogs and foxes. This skin disease also has zoonotic potential. Infestation is also called acariasis, which refers to a rash that is caused by mites.
Sarolaner, sold under the brand name Simparica, is an ectoparasiticide veterinary medication for the treatment of flea and tick infestations in dogs. It is also used off-label to control sarcoptic mange and demodectic mange.
References
- 1 2 3 "Advantage Multi for Dogs- imidacloprid moxidectin solution". DailyMed. 18 April 2018. Retrieved 29 May 2020.
- 1 2 3 "Advantage Multi for Cats- imidacloprid and moxidectin solution". DailyMed. 18 April 2018. Retrieved 28 May 2020.
- ↑ "Advocate EPAR". European Medicines Agency (EMA). Retrieved 29 January 2021.
- ↑ "Advantage Multi for Dogs". U.S. Food and Drug Administration (FDA). Retrieved 28 May 2020.
- ↑ "Advantage Multi for Cats". U.S. Food and Drug Administration (FDA). Retrieved 28 May 2020.
- 1 2 3 "Imoxi Topical Solution for Dogs". U.S. Food and Drug Administration (FDA). Retrieved 28 May 2020.
This article incorporates text from this source, which is in the public domain . - 1 2 "Imoxi Topical Solution for Cats". U.S. Food and Drug Administration (FDA). Retrieved 28 May 2020. This article incorporates text from this source, which is in the public domain .
- 1 2 3 4 5 6 "Imoxi Topical Solution for Dogs FOIA Drug Summary". U.S. Food and Drug Administration (FDA). Retrieved 28 May 2020. This article incorporates text from this source, which is in the public domain .
- 1 2 3 "Imoxi Topical Solution for Cats FOIA Drug Summary". U.S. Food and Drug Administration (FDA). Retrieved 28 May 2020. This article incorporates text from this source, which is in the public domain .
- ↑ "FDA Approves Generic Animal Drug for Parasite Protection in Cats". U.S. Food and Drug Administration (FDA) (Press release). 28 May 2020. Retrieved 28 May 2020. This article incorporates text from this source, which is in the public domain .
